EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

A Case-Control Study of Hepatitis C Virus Reinfection in Incarcerated Patients in California Receiving Medication for Opioid Use Disorder

Joey Shemuel iD, Amy T Krawiec iD, Donna Kalauokalani, Kimberley D Lucas iD

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf192 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Joey Shemuel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of California, Davis, California, USA. Hauptthemen laut MEDLINE: Opioid-Related Disorders, Prisoners, Hepatitis C, Reinfection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Incarcerated people are disproportionately burdened with hepatitis C virus (HCV) infection and experience elevated risk of reinfection following treatment. Medication for opioid use disorder (MOUD) has been shown to reduce, but not eliminate, reinfection. Research is lacking on patient-level factors associated with HCV reinfection in incarcerated populations in the United States receiving MOUD.

Methods

We conducted a case-control study from secondary data analysis of health records among people incarcerated in California state prisons who initiated HCV treatment, achieved sustained virologic response, and began MOUD before sustained virologic response. Case-patients were reinfected within 1 year; controls remained HCV-negative at 1 year.

Results

Eligible subjects (50 cases; 108 controls) were predominantly male (96.2%), Hispanic/Latinx (62.7%) or White (29.1%), and median age 36 (range, 23–60) years. HCV reinfection was independently associated with injection drug use (adjusted odds ratio [aOR] = 3.4; 95% confidence interval [CI], 1.3–8.5), unsterile tattooing (aOR = 3.4; 95% CI, 1.2–9.9), methamphetamine use (aOR = 2.5; 95% CI, 1.0–6.1), younger age (aOR = 0.7; 95% CI, .5–.9; units = 5 years), and lower adherence to adequately dosed (≥16 mg/day) buprenorphine (aOR = 0.7; 95% CI, .6–1.0; units = 0.25, aOR = 0.3; 95% CI, .1–.9; units = 1.0).

Conclusions

Even with complete MOUD adherence, conferring a 70% protective effect for HCV reinfection, patients reported ongoing risk behaviors. Injection drug use, methamphetamine use, and unsterile tattooing also increase the risk of other bloodborne or skin and soft tissue infections and overdose. Improved health outcomes could be achieved with integrating enhanced monitoring of MOUD with expanded harm reduction including syringe services and contingency management for treatment of stimulant use disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Related DisordersPrisonersHepatitis CReinfectionHumansMaleCase-Control StudiesAdultFemaleCaliforniaMiddle AgedYoung AdultRisk FactorsAntiviral AgentsSubstance Abuse, IntravenousOpiate Substitution TreatmentHepacivirus

Stichwörter der Autor:innen

harm reductionhepatitis Copioid use disorderpeople who inject drugsprison

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, University of California, Davis, California, USA.
  • Medical Services Division, California Correctional Health Care Services, Elk Grove, California, USA.

ORCID-Profile: Joey Shemuel, Amy T Krawiec, Kimberley D Lucas

Zitieren

APA

Shemuel, J., Krawiec, A. T., Kalauokalani, D., & Lucas, K. D. (2025). A Case-Control Study of Hepatitis C Virus Reinfection in Incarcerated Patients in California Receiving Medication for Opioid Use Disorder. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf192

Vancouver

Shemuel J, Krawiec AT, Kalauokalani D, Lucas KD. A Case-Control Study of Hepatitis C Virus Reinfection in Incarcerated Patients in California Receiving Medication for Opioid Use Disorder. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf192

BibTeX
@article{Shemuel2025,
  author = {Shemuel, Joey and Krawiec, Amy T and Kalauokalani, Donna and Lucas, Kimberley D},
  title = {A Case-Control Study of Hepatitis C Virus Reinfection in Incarcerated Patients in California Receiving Medication for Opioid Use Disorder},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf192}
}
Kostenlos starten →